O’Melveny’s Lovenworth, Hayes, Savaresse Author Law360 Article on Gene Patents

July 16, 2013

On July 15, 2013, Law360 published an article by O’Melveny & Myers senior counsel Stanton Lovenworth, associate Christina Hayes, and summer associate Gerard Savaresse, titled “The High Court’s Dangerous Reset On Gene Patents.”  The piece describes various court rulings surrounding the question of whether human DNA can be patented, including the recent US Supreme Court ruling that isolated genomic DNA is not patent-eligible, but cDNA, a synthesized form, remains protectable.  The authors argue that “the greatest danger in the Court’s decision lies in its potential to upset the patent law’s delicate balance between incentives to spur innovation and the impediments to the free flow of information … some research may now go unfunded, some resources unexploited, and some ideas unexplored.”

Lovenworth is a member of O'Melveny's Health Care and Life Sciences Practice, and Hayes is a member of the Firm's Litigation Department.  Both reside in O'Melveny's York office.